Many patients with atrial fibrillation (AFib) are not receiving any therapy to prevent stroke, and Geoffrey Barnes, MD, ...
EASD 2026: The combination of semaglutide/cagrilintide altered food-cue responses and showed a 22.4% estimated weight ...
Eli Lilly announced that the FDA has expanded the US approval of baricitinib (Olumiant) to include patients aged 12 years and ...
The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer. The FDA's action identifies the application as ...
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day ...
Geoffrey Barnes, MD, on why a careful exam is the first line of detection and which 2 risk factors primary care clinicians can actually change. Many patients with atrial fibrillation (AFib) have no ...
, on why a careful exam is the first line of detection and which 2 risk factors primary care clinicians can actually change.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results